| Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer MW Kramer, V Altieri, R Hurle, L Lusuardi, AS Merseburger, J Rassweiler, ... European urology focus 3 (6), 567-576, 2017 | 214 | 2017 |
| En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc … MW Kramer, JJ Rassweiler, J Klein, A Martov, N Baykov, L Lusuardi, ... World journal of urology 33, 1937-1943, 2015 | 191 | 2015 |
| Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis MW Kramer, DO Escudero, SD Lokeshwar, R Golshani, OO Ekwenna, ... Cancer 117 (6), 1197-1209, 2011 | 152 | 2011 |
| Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44 R Golshani, L Lopez, V Estrella, M Kramer, N Iida, VB Lokeshwar Cancer research 68 (2), 483-491, 2008 | 151 | 2008 |
| Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer S Waalkes, F Atschekzei, MW Kramer, J Hennenlotter, G Vetter, ... BMC cancer 10, 1-6, 2010 | 135 | 2010 |
| Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer MW Kramer, T Bach, M Wolters, F Imkamp, AJ Gross, MA Kuczyk, ... World journal of urology 29, 433-442, 2011 | 116 | 2011 |
| An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round Delphi survey, and a consensus meeting JYC Teoh, S MacLennan, VWS Chan, J Miki, HY Lee, E Chiong, LS Lee, ... European urology 78 (4), 546-569, 2020 | 107 | 2020 |
| Treatment of high-grade non–muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations … MO Grimm, AG van der Heijden, M Colombel, T Muilwijk, ... European urology 78 (5), 690-698, 2020 | 97 | 2020 |
| HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer MW Kramer, R Golshani, AS Merseburger, J Knapp, A Garcia, ... European urology 57 (1), 86-94, 2010 | 95 | 2010 |
| Tm: YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience M Wolters, MW Kramer, JU Becker, M Christgen, U Nagele, F Imkamp, ... World journal of urology 29, 429-432, 2011 | 93 | 2011 |
| Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer S Waalkes, AS Merseburger, MW Kramer, TRW Herrmann, G Wegener, ... Cancer causes & control 21, 1905-1910, 2010 | 85 | 2010 |
| Involvement of decreased Galectin‐3 expression in the pathogenesis and progression of prostate cancer AS Merseburger, MW Kramer, J Hennenlotter, P Simon, J Knapp, ... The Prostate 68 (1), 72-77, 2008 | 81 | 2008 |
| Developing proteomic biomarkers for bladder cancer: towards clinical application M Frantzi, A Latosinska, L Flühe, MC Hupe, E Critselis, MW Kramer, ... Nature Reviews Urology 12 (6), 317-330, 2015 | 78 | 2015 |
| Current evidence of transurethral Ho: YAG and Tm: YAG treatment of bladder cancer: update 2014 MW Kramer, M Wolters, H Cash, S Jutzi, F Imkamp, MA Kuczyk, ... World journal of urology 33, 571-579, 2015 | 74 | 2015 |
| HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer VB Lokeshwar, V Estrella, L Lopez, M Kramer, P Gomez, MS Soloway, ... Cancer Research 66 (23), 11219-11227, 2006 | 66 | 2006 |
| Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets DS Morera, MS Hennig, A Talukder, SD Lokeshwar, J Wang, ... British journal of cancer 117 (10), 1507-1517, 2017 | 61 | 2017 |
| A real-world data study to evaluate treatment patterns, clinical characteristics and survival outcomes for first-and second-line treatment in locally advanced and metastatic … G Niegisch, H Gerullis, SW Lin, J Pavlova, A Gondos, A Rudolph, G Haas, ... Journal of Cancer 9 (8), 1337, 2018 | 60 | 2018 |
| Retrospective cost analysis of a single-center reusable flexible ureterorenoscopy program: a comparative cost simulation of disposable fURS as an alternative T Ozimek, MH Schneider, MC Hupe, JR Wiessmeyer, J Cordes, ... Journal of Endourology 31 (12), 1226-1230, 2017 | 57 | 2017 |
| Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival AS Merseburger, MW Kramer, J Hennenlotter, J Serth, S Kruck, A Gracia, ... World journal of urology 26, 637-642, 2008 | 56 | 2008 |
| Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence JS Knapp, SD Lokeshwar, U Vogel, J Hennenlotter, C Schwentner, ... World journal of urology 31, 351-358, 2013 | 54 | 2013 |
